Prenatal SSRI Exposure Linked to Functional Constipation in Offspring
By Elana Gotkine HealthDay Reporter
FRIDAY, Dec. 13, 2024 -- Prenatal exposure to selective serotonin reuptake inhibitors (SSRIs) is associated with an increased risk of functional constipation developing in offspring, according to a study published online Dec. 10 in Molecular Psychiatry.
Helene Kildegaard, M.D., from the Hans Christian Andersen Children's Hospital in Odense, Denmark, and colleagues examined associations between gestational SSRI exposure and offspring disorders of gut-brain interaction (DGBI) using population-based registries. All single-birth Danish children born in 1997 to 2015 were included. Children born to mothers who continued SSRIs during pregnancy were compared to those whose mothers discontinued SSRIs before pregnancy.
Of the 1,158,560 children, 1.9 and 2.6 percent were exposed to SSRIs prenatally and were born to mothers who discontinued SSRIs before pregnancy, respectively. The researchers found that the 15-year cumulative incidence of any DGBI was 15.5 and 14.7 percent in the SSRI-exposed and unexposed groups, respectively. The risk of DGBIs was increased overall in SSRI-exposed children (hazard ratio, 1.08), with the increase driven by functional constipation but not by functional nausea and vomiting or functional abdominal pain disorders.
"Our finding that functional constipation is increased following prenatal SSRI exposure should not be taken as a directive to change clinical practice or current recommendations for antidepressant treatment in pregnancy," the authors write. "Treating depression in pregnancy is a high priority, as untreated depression can have significant adverse consequences on both the mother and the fetus."
One author disclosed ties to the pharmaceutical industry.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted December 2024
Read this next
Chatbots Do Well Responding to Low- and High-Risk Suicide Questions
THURSDAY, Aug. 28, 2025 -- Popular chatbots generally perform well in responding to very high-risk and very low-risk questions about suicide, according to a study published online...
Variables Associated With Heart Failure Compared for Men and Women
THURSDAY, Aug. 28, 2025 -- Asthma, depression, anxiety, and hypothyroidism are associated with heart failure with preserved ejection fraction (HFpEF) and heart failure with...
Cancer Survivors More Likely to Take Rx for Mental Health Conditions
THURSDAY, Aug. 28, 2025 -- U.S. cancer survivors are significantly more likely to take medications for depression and anxiety compared with noncancer survivors, according to a...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.